Clinical Trial Detail

NCT ID NCT03793478
Title Safety and Effectiveness of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Daiichi Sankyo, Inc.
Indications

acute myeloid leukemia

Therapies

Etoposide

Cytarabine + Fludarabine + Methotrexate + Prednisolone + Quizartinib

Cytarabine + Daunorubicin + Fludarabine + Methotrexate + Prednisolone + Quizartinib

Cytarabine + Daunorubicin + Fludarabine + Hydrocortisone + Methotrexate + Quizartinib

Cytarabine + Fludarabine + Methotrexate + Prednisolone

Quizartinib

Age Groups: adult child

Additional content available in CKB BOOST